---
figid: PMC7754013__JCMM-24-13564-g001
figtitle: MicroRNAs in osteogenic transdifferentiation of VSMCs
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Oryctolagus cuniculus
- Mouse mammary tumor virus
pmcid: PMC7754013
filename: JCMM-24-13564-g001.jpg
figlink: pmc/articles/PMC7754013/figure/jcmm16005-fig-0001/
number: F1
caption: Schematic representation of microRNAs in osteogenic transdifferentiation
  of VSMCs. Upon BMPs binding to the receptor complex, Smad proteins translocate into
  the nucleus and modulate gene expression transcriptionally by directly interacting
  with the promoter region of target genes (such as Runx2 and Osterix) or post‐transcriptionally
  through regulating miRs synthesis. Then, these osteoblast transcription factors
  regulate opulent bone matrix proteins expression and promote transdifferentiation
  of VSMCs to osteoblast‐like cells. MicroRNAs regulate osteogenic transdifferentiation
  of VSMCs through targeting key factors in the BMP/Smad/Runx2 signalling pathway
  and several inhibitors of osteoblastic differentiation. Besides, some miRs are able
  to regulate the expression of proteins involved in VSMCs differentiation, migration
  and contractility. ADAMTS‐7, a disintegrin and metalloproteinase with thrombospondin
  motifs 7; ACVR2A, A receptor type IIA; ALP, alkaline phosphatase; BMPR, Bone morphogenetic
  proteins receptor; BMPs, Bone morphogenetic proteins; Cbfβ, core‐binding factor
  beta; COMP, cartilage oligomeric matrix protein; CTNNBIP1, b‐catenin interacting
  protein 1; DNMT3a, DNA methyltransferase 3A; Ets1, endothelial transcription factor
  1; HDAC2, histone deacetylase 2; HDAC4, histone deacetylase 4; Hoxa2, Homeobox A2;
  IGF‐2, Insulin‐like growth factor 2; Mef2c, myocyte enhancer factor 2C; MMP2, matrix
  metallopeptidase 2; RhoB, ras homolog gene family member B; SATB2, Special AT‐rich
  sequence‐binding protein 2; Wnt, wingless‐type MMTV integration site; α‐SMA, smooth
  muscle actin‐α.  stimulation;  inhibition
papertitle: MicroRNAs are critical in regulating smooth muscle cell mineralization
  and apoptosis during vascular calcification.
reftext: Shan‐shan Wang, et al. J Cell Mol Med. 2020 Dec;24(23):13564-13572.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9184099
figid_alias: PMC7754013__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7754013__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7754013__JCMM-24-13564-g001.html
  '@type': Dataset
  description: Schematic representation of microRNAs in osteogenic transdifferentiation
    of VSMCs. Upon BMPs binding to the receptor complex, Smad proteins translocate
    into the nucleus and modulate gene expression transcriptionally by directly interacting
    with the promoter region of target genes (such as Runx2 and Osterix) or post‐transcriptionally
    through regulating miRs synthesis. Then, these osteoblast transcription factors
    regulate opulent bone matrix proteins expression and promote transdifferentiation
    of VSMCs to osteoblast‐like cells. MicroRNAs regulate osteogenic transdifferentiation
    of VSMCs through targeting key factors in the BMP/Smad/Runx2 signalling pathway
    and several inhibitors of osteoblastic differentiation. Besides, some miRs are
    able to regulate the expression of proteins involved in VSMCs differentiation,
    migration and contractility. ADAMTS‐7, a disintegrin and metalloproteinase with
    thrombospondin motifs 7; ACVR2A, A receptor type IIA; ALP, alkaline phosphatase;
    BMPR, Bone morphogenetic proteins receptor; BMPs, Bone morphogenetic proteins;
    Cbfβ, core‐binding factor beta; COMP, cartilage oligomeric matrix protein; CTNNBIP1,
    b‐catenin interacting protein 1; DNMT3a, DNA methyltransferase 3A; Ets1, endothelial
    transcription factor 1; HDAC2, histone deacetylase 2; HDAC4, histone deacetylase
    4; Hoxa2, Homeobox A2; IGF‐2, Insulin‐like growth factor 2; Mef2c, myocyte enhancer
    factor 2C; MMP2, matrix metallopeptidase 2; RhoB, ras homolog gene family member
    B; SATB2, Special AT‐rich sequence‐binding protein 2; Wnt, wingless‐type MMTV
    integration site; α‐SMA, smooth muscle actin‐α.  stimulation;  inhibition
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir31
  - Mir30e
  - Igf2
  - Mir29a
  - Pdlim3
  - Ets1
  - Kcnh8
  - Mir133a1
  - Mir133b
  - Mir204
  - Mir30b
  - Mir27a
  - Wnt7b
  - Samd8
  - Samd1
  - Samd5
  - Mir145
  - Cebpz
  - Hdac2
  - Msx2
  - Runx2
  - Ctnnbip1
  - Acvr2a
  - Hdac4
  - Mir221
  - Mir222
  - Hdac5
  - Mir34b
  - Rhob
  - Stab2
  - MIR31
  - MIR30E
  - IGF2
  - MIR29A
  - ETS1
  - MIR133A
  - MIR133B
  - MIR204
  - MIR30B
  - SAMD8
  - SAMD1
  - MIR145
  - HDAC2
  - MSX2
  - RUNX2
  - CTNNBIP1
  - ACVR2A
  - HDAC4
  - MIR221
  - MIR222
  - HDAC5
  - MIR34B
  - RHOB
  - STAB2
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - MIR29B1
  - MIR27A
  - WNT7B
  - SAMD5
  - CEBPZ
  - SP7
  - ACTA1
  - MIR2861
  - MIR3960
  - alp
  - Alpl
  - Ccl21a
  - Ccl27a
  - Slpi
  - Asrgl1
  - Atrnl1
  - Bmpr1a
  - Mir145a
  - Acta2
  - Mir2861
  - Hdac6
  - Mir3960
  - Hydroxyapatite
---
